Related Articles
Malignant melanoma associates with deficient IFN-induced STAT 1 phosphorylation
The antagonist of the JAK-1/STAT-1 signaling pathway improves the severity of cerulein-stimulated pancreatic injury via inhibition of NF-κB activity
Effects of treatment with an Hsp90 inhibitor in tumors based on 15 phase II clinical trials
The JAK/STAT signaling cascade in gastric carcinoma (Review)
Current status and prospects of GREM1 research in cancer (Review)